MTNB vs SO · rev $1.1M vs P/E 22, rev $29.55B
Matinas BioPharma Holdings Inc (MTNB) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
MTNB currently screens at market cap $5.6M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the MTNB and SO stock pages for the full models.
Not investment advice.